Returns On Capital Signal Tricky Times Ahead For Intco Medical Technology (SZSE:300677)

Simply Wall St18:44 ET

Intco Medical Technology (300677.SZ): The company is currently operating at full production and sales.

On March 18, Gelonghui reported that Intco Medical Technology (300677.SZ) stated on the investor interaction platform that the company will continue to closely monitor the innovation and application of emerging technologies. The company is currently maintaining full production and sales.

Gelonghui FinanceMar 18 03:23 ET

Investors Aren't Entirely Convinced By Intco Medical Technology Co., Ltd.'s (SZSE:300677) Earnings

Simply Wall StFeb 28 20:02 ET

Can Mixed Fundamentals Have A Negative Impact on Intco Medical Technology Co., Ltd. (SZSE:300677) Current Share Price Momentum?

Simply Wall StFeb 13 19:13 ET

Intco Medical Technology (300677.SZ): has cumulatively repurchased 0.3033 million shares.

On February 5, Gelonghui reported that Intco Medical Technology (300677.SZ) announced that as of January 31, 2025, the company has repurchased a total of 0.3033 million shares through a special securities account for share buybacks via centralized bidding trading, accounting for 0.0469% of the company's total share capital (based on a total share capital of 646,193,496 shares as of January 27, 2025). The highest Fill Price was 21.62 yuan/share, the lowest Fill Price was 20.99 yuan/share, and the total amount of the transaction was 6.4676 million yuan (excluding transaction costs).

Gelonghui FinanceFeb 5 05:00 ET

Intco Medical Technology (300677.SZ) announced an earnings forecast, expecting net income for the year 2024 to be between 1.2 billion and -1.5 billion yuan, representing a significant year-on-year growth of 213.32% to 291.65%.

Intco Medical Technology (300677.SZ) released its performance forecast for 2024, with the company expecting...

Zhitong FinanceJan 23 05:04 ET